Wednesday, December 31, 2014

(LML) BIKASH Training Calendar-2015

Leprosy Mailing List – December 31,  2014 

Ref.:  (LML)   BIKASH Training Calendar-2015

From:  Gopal Gurung, BIKASH Nepal

Dear Dr. Pieter,


Warm greetings from Nepal!

Please circulate the attached training calendar to all Leprosy Mailing List (LML) readers. Thank you so much!


With our best wishes  and Happy New Year 2015!!!




Gopal Gurung

Program Manager


PO Box: 28

Pokhara-15, Kaski


Ph: 00977 61 430562

Fax: 00977 61 430940



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<

This email has been checked for viruses by Avast antivirus software.

Sunday, December 28, 2014

(LML) WHO Goodwill Ambassador's Newsletter Number 71, December 2014 Issue


Leprosy Mailing List – December 28,  2014 

Ref.:    (LML) WHO Goodwill Ambassador's Newsletter Number 71, December 2014 Issue


From:  Hiroe Soyagimi, SMHF, Tokyo, Japan


Dear Dr. Schreuder and Friends,



Warm greetings from Sasakawa Memorial Health Foundation in Tokyo. We have uploaded our latest edition of "WHO Goodwill Ambassador's Newsletter No.71, Decebmer 2014" to our website. 


Please visit to obtain electronic version of this issue. 


In this issue we feature articles about ...


MESSAGE : My Promise to the Dalai Lama


REPORT: Building Momentum in Morocco - 4th regional symposium on leprosy and human rights paves way to Geneva in 2015.


REPORT: Why Heritage Matters - International workshop motivates participants to do more to preserve the past.




AMBASSADOR'S JOURNAL: The Road from Rabat - Learning about Morocco's leprosy elimination activities, sanatorium visits in Spain and Portugal and an appointment with the prime minister in India are among the Goodwill Ambassador's recent activity highlights.


NEWS: India's Midterm Report Card - Evaluators make recommendations to strengthen leprosy eradication program.






We hope you enjoy our latest Newsletter!



Hiroe Soyagimi

Sasakawa Memorial Health Foundaion


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<

This email has been checked for viruses by Avast antivirus software.

Sunday, December 21, 2014

(LML) Announcement Leprosy Research Initiative: deadline for submission of Letter of Intent

Leprosy Mailing List – December 21 ,  2014 

Ref.:  (LML)  Announcement Leprosy Research Initiative: deadline for submission of Letter of Intent


From:  Nicole Dinnissen, NLR, Amsterdam, The Netherlands


Dear all,



The Leprosy Research Initiative (LRI) is a combined venture of the Netherlands Leprosy Relief (NLR), American Leprosy Missions (ALM), German Leprosy and Tuberculosis Relief Association (GLRA) and The Leprosy Mission Canada (TLMC). Guided by an allied policy with clearly defined research priorities, the four partners have established a joint fund to support leprosy research. The joint fund will be reserved for research that is exclusively or strongly related to leprosy. Additional resources will be actively sought for research in the field of general disabilities and for research aimed at different diseases (e.g. other NTDs, TB and diabetes) in combination with leprosy.


Researchers interested to apply for funding by the LRI are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research. The LoI should use the format provided on the LRI website ( ). Applications that do not follow this format will not be considered.


A Letter of Intent may be submitted at any time during the year. However, to be considered for the budget round 2016, LoIs should be submitted by April 1st, 2015 by e-mail to the LRI Secretariat, c/o Ms. Nicole Dinnissen ( ). This letter will be screened by the LRI Steering Committee (SC). If the feedback by the SC is positive, the applicants will be invited to submit a full proposal before the next deadline (June 1st). 


With kind regards,



Nicole Dinnissen


Leprosy Research Initiative (LRI)

c/o Netherlands Leprosy Relief

Postbus / P.O. Box 95005

1090 HA Amsterdam

The Netherlands


+31 20 5950534





LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<


This email has been checked for viruses by Avast antivirus software.

(LML) In Memoriam Robert C. Hastings

Leprosy Mailing List – December 21,  2014 

Ref.:    (LML) In Memoriam Robert C. Hastings

From:  David M. Scollard, NHDP, Louisiana,  USA

Dear Pieter,

Dr. Robert C. Hastings, pharmacologist and internationally distinguished leprologist, passed away on Dec. 15, 2014, at age 76, after a long illness.  Affectionately known to colleagues around the world as ‘Bob’, he sometimes described himself as ‘a country boy from the mountains of Tennessee’, where he was born.  He earned his medical degree at the University of Tennessee and a PhD in Pharmacology from Tulane University.  He was a Commissioned Officer in the United States Public Health Service, and spent his entire career at the USPHS Hospital at Carville, Louisiana.   In addition to his clinical duties there, he was a leading investigator in studies of the pharmacology of several important drugs used in leprosy.  Over a remarkable 40-year career, from 1968 to 1998, he was an author or co-author on nearly 80 peer-reviewed publications dealing with anti-mycobacterial and anti-inflammatory drugs in this disease.  This included seminal work on the treatment of leprosy reactions with thalidomide.  He retired as Chief of the Laboratory Research Branch of the US National Hansen’s Disease Programs in 1994.

Bob Hastings is undoubtedly best known internationally for his remarkable career as an editor.  He was the Editor of The International Journal of Leprosy from 1979 – 2002, encouraging and promoting the publication of many reports from young investigators and spending countless hours assisting them in revising manuscripts for publication.   He was also the Editor of ‘Leprosy’, the textbook published in 1985 with contributions from the major leprologists of the time.  This has been the standard text on this disease for more than 25 years, and is on the shelf of nearly everyone working on this disease today.   He dedicated this text to his granddaughter, born in 1983, ‘. . . in the hopes that her children, and her children’s generation all over the world, [would] be free from leprosy’.   Bob was a skilled and empathetic physician, an outstanding intellect, and a critical thinker.  He was self-effacing and genial in his interactions with colleagues ranging from prominent scientists to those just beginning their careers.  In his farewell as the Editor of the Journal he wished, to those continuing in the field,    ‘. . . every success in making further contributions to some of God’s most needy people, leprosy patients.’ He will be greatly missed and long remembered for his contributions to the fight against leprosy. 



David M. Scollard, M.D., Ph.D.


National Hansen’s Disease Programs

Tel:  225-756-3713 (Clinical) or 756-3776 (Administration)

Fax:  225-756-3819 or 756-3806



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<


This email has been checked for viruses by Avast antivirus software.

Wednesday, December 3, 2014

(LML) Input into London Declaration on NTDs Scorecard

Leprosy Mailing List – December 3,  2014 

Ref.:   (LML)  Input into London Declaration on NTDs Scorecard

From:  Lenka Nahodilova and Wim van Brakel, ILEP, London, UK

Dear Colleagues,

There is an opportunity for all stakeholders in the leprosy field to highlight their current involvement in research on leprosy.

The Uniting to Combat NTDs group, sponsored by Bill and Melinda Gates Foundation (BMGF), is currently collecting data for the 3rd Annual Report on progress towards targets, which were defined in the WHO Roadmap on NTDs (2011) and endorsed by the London Declaration on NTDs in 2012.

ILEP is representing the leprosy field in the London Declaration Disease Specific Working Group. In this capacity, we have been assigned the task of collecting and collating information on current research in leprosy in order to provide input into the 3rd Annual Report and its Scorecard. Dr Wim van Brakel has been assigned to lead this task.

As part of the process we are currently collecting information on research projects in leprosy. Hence we would be grateful if you would share with us information on large(r) research projects that your organization is currently undertaking or supporting or research projects that will start in the future. In general, we are interested in research projects that will be finished by 2018, or implemented by 2020. If relevant to the London Declaration targets, projects submitted in time may be included in the Uniting to Combat NTDs 3rd Annual Report.

If you would like to take part in this survey, please read the attachment for more details and fill in the short questionnaire which is enclosed.

Please kindly send the filled in questionnaire by Monday 8 December 2014 to Lenka Nahodilova, email address:

Thank you very much for your kind cooperation!

With kind regards

Lenka Nahodilova and Wim van Brakel.

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<

This email has been checked for viruses by Avast antivirus software.

(LML) INFOLEP's selection of recent publications on leprosy

Leprosy Mailing List – December 3,  2014 

Ref.:  (LML) INFOLEP's  selection of recent publications on leprosy

From:  Jiske Erlings, NLR, Amsterdam, The Netherlands

Dear Pieter,

Greetings from Infolep!

Below you will find a selection of recent publications on leprosy. Feel free to contact me to receive the full text versions if a link to the full text is not included. You might have heard that we are working on expanding the Infolep portal with publications on cross-cutting issues in Neglected Tropical Diseases. An overview of this rapidly growing collection can be found here:

Do you miss something on this list or do you have publications (articles, manuals, theses) on leprosy or related subjects to include in the website Please let me know!

You may contact me at

Did you know that you can contact me for all kinds of Library & Information services?

Read more about this at

With kind regards,


Jiske Erlings

INFOLEP Information specialist


Doctoral Thesis


Stigma and stigma interventions related to leprosy and tuberculosis in Thailand / Silatham Sermrittirong. Free University Amsterdam, 2014.
Read full text:


New Journal Articles

Anish L, Nagappa M, Mahadevan A, Taly AB. Neuropathy in elderly: lessons learnt from nerve biopsy. Age Ageing. 2014 Nov 1. pii: afu171. Read abstract:

Araújo AE, Aquino DM, Goulart IM, Pereira SR, Figueiredo IA, Serra HO, Fonseca PC, Caldas Ade J. [Neural complications and physical disabilities in leprosy in a capital of northeastern Brazil with high endemicity]. Rev Bras Epidemiol. 2014 Dec;17(4):899-910. English, Portuguese. Read full text:

Barbieri RR, Sales AM, Illarramendi X, Moraes MO, Nery JA, Moreira SJ, Sarno EN, Machado AD, Bozza FA. Diagnostic challenges of single plaque-like lesion paucibacillary leprosy. Mem Inst Oswaldo Cruz. 2014 Oct 14;0:0. Read full text:

Berrington WR, Kunwar CB, Neupane K, van den Eeden SJ, Vary JC Jr, Peterson GJ, Wells RD, Geluk A, Hagge DA, Hawn TR. Differential Dermal Expression of CCL17 and CCL18 in Tuberculoid and Lepromatous Leprosy. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3263. Read Full text:

Boulton AJ. Diabetic neuropathy and foot complications. Handb Clin Neurol. 2014;126:97-107. Read abstract:

Cabral-Miranda W, Chiaravalloti Neto F, Barrozo LV. Socio-economic and environmental effects influencing the development of leprosy in Bahia, north-eastern Brazil. Trop Med Int Health. 2014 Sep 22. Read abstract:

Contreras Mejía MD, Porto Dos Santos M, da Silva GA, da Motta Passos I, Naveca FG, da Graça Souza Cunha M, Ozório Moraes M, de Paula L. Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas state, Brazil. J Clin Microbiol. 2014 Oct 1. pii: JCM.01688-14. Read abstract:

Cunha SS. Review of chemoprophylaxis in leprosy contacts. Rev Panam Salud Publica. 2014 Sep;36(3):208. PubMed PMID: 25418774. Full text online:

Dupnik KM, Bair TB, Maia AO, Amorim FM, Costa MR, Keesen TS, Valverde JG, Queiroz MD, Medeiros LL, de Lucena NL, Wilson ME, Nobre ML, Johnson WD, Jeronimo SM. Transcriptional changes that characterize the immune reactions of leprosy. J Infect Dis. 2014 Nov 14. pii: jiu612. Read abstract:

Freitas LR, Duarte EC, Garcia LP. Leprosy in Brazil and its association with characteristics of municipalities: ecological study, 2009-2011. Trop Med Int Health. 2014 Oct;19(10):1216-25. Read abstract:

Gaud S, Sauvée M, Debouverie M. Neurologic diseases in a rural tropical area: experience at a primary health care center in the Boeny region of Madagascar. Med Sante Trop. 2014 Oct 8. Read abstract:

Han XY, Aung FM, Choon SE, Werner B. Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries. Am J Clin Pathol. 2014 Oct;142(4):524-32. Read abstract:

Hundeiker M, Bassukas ID. [The forthcoming history of leprosy]. Pneumologie. 2014 Sep;68(9):613-8. German. Read abstract:

Hussain T, Kulshreshtha KK, Yadav VS, Katoch K. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases  (Leprosy, Tuberculosis), HIV infections and Normal Healthy Adults : A comparative analysis of studies in different regions of India. J Immunoassay Immunochem. 2014 Oct 28. Read abstract:

Kamath S, Vaccaro SA, Rea TH, Ochoa MT. Recognizing and managing the immunologic reactions in leprosy. J Am Acad Dermatol. 2014 Oct;71(4):795-803. Read abstract:

Marta SN, Sgavioli C, Saraiva PP, Carvalho RS, Nogueira MG, Monti FC, Virmond M. Evaluation of light-touch sensation in the buccal mucosa of leprosy patients. Clin Oral Investig. 2014 Nov;18(8):1913-7. Read abstract:

Medeiros MF, Rodrigues MM, Vital RT, da Costa Nery JA, Sales AM, de Andrea Hacker M, Ferreira H, Chimelli L, Sarno EN, Antunes SL. CXCL10, MCP-1, and Other Immunologic Markers Involved in Neural Leprosy. Appl Immunohistochem Mol Morphol. 2014 Sep 15. Read abstract:

Meredith A, Pozo JD, Smith S, Milne E, Stevenson K, McLuckie J. Leprosy in red squirrels in Scotland. Vet Rec. 2014 Sep 20;175(11):285-6. Read abstract:

Moura RS, Penna GO, Fujiwara T, Pontes MA, Cruz R, Gonçalves Hde S, Penna ML, Cardoso LP, Stefani MM, Bührer-Sékula S. Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier. J Immunol Methods. 2014 Oct;412:35-41. Read abstract:

Neder L, Rondon DA, Cury SS, da Silva CA. Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy. J Pediatr (Rio J). 2014 Sep-Oct;90(5):457-63. Read full text:

Nery JS, Pereira SM, Rasella D, Penna ML, Aquino R, Rodrigues LC, Barreto ML, Penna GO. Effect of the Brazilian conditional cash transfer and primary health care programs on the new case detection rate of leprosy. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3357. Full text

Nolen L, Haberling D, Scollard D, Truman R, Rodriguez-Lainz A, Blum L, Blaney D.
Incidence of Hansen's Disease - United States, 1994-2011. MMWR Morb Mortal Wkly Rep. 2014 Oct 31;63(43):969-72. Read full text:

Patnaik N, Agarwal S, Sharma S, Sharma S, Pandhi D. Evaluation of key histologic variables in skin biopsies of patients of borderline leprosy with type 1 lepra reaction. Indian J Dermatol Venereol Leprol. 2014 Sep-Oct;80(5):402-8. Read full text:

Peters RM, Dadun, Van Brakel WH, Zweekhorst MB, Damayanti R, Bunders JF, Irwanto. The Cultural Validation of Two Scales to Assess Social Stigma in Leprosy. PLoS Negl Trop Dis. 2014 Nov 6;8(11):e3274. Read full text:

Pieri FM, Touso MM, Rodrigues LB, Yamamura M, Pinto IC, Dessunti EM, Crispim Jde A, Ramos AC, Arroyo LH, Neto MS, Garcia MC, Popolin MP, Silveira TR, Arcêncio RA. Patients' perceptions on the performance of a local health system to eliminate leprosy, paraná state, Brazil. PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3324. Read full text:

Polat Ekinci A, Karabacak E, Tekin L, Ozarmağan G, Ozçakar L.
Ultrasound imaging for the follow-up of leprosy patıents: a pictorial essay. Br J Dermatol. 2014 Sep 21. Read abstract:

Ranganathan AT, Khalid W, Saraswathy PK, Chandran CR, Mahalingam L. Periodontal findings in patients with Hansen's disease. Asian Pac J Trop Med. 2014 Sep;7S1:S108-10. Read abstract:

Santos VS, Santos LC, Lôbo LV, Lemos LM, Gurgel RQ, Cuevas LE. Leprosy and Disability in Children Younger than 15 Years in an Endemic Area of Northeast Brazil. Pediatr Infect Dis J. 2014 Nov 11. Abstract:

Segundo JB, da Silva MA, Filho WE, Nascimento AC, Vidal FC, Bezerra GF, Viana GM, Nascimento MD. Cerebral aspergillosis in a patient with leprosy and diabetes: a case report. BMC Res Notes. 2014 Oct 4;7(1):689. Read full text:

Shen J, Yan L, Yu M, Li J, Yu X, Zhang G. Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China. Int J Dermatol. 2014 Sep 30. Read abstract:

Tsukamoto Y, Maeda Y, Makino M. Evaluation of major membrane protein-I as a serodiagnostic tool of pauci-bacillary leprosy. Diagn Microbiol Infect Dis. 2014 Sep;80(1):62-5. Read abstract:

Wambier CG, Ramalho LN, Frade MA, Foss NT. NFκB activation in cutaneous lesions of leprosy is associated with development of multibacillary infection. J Inflamm Res. 2014 Aug 25;7:133-8. Read full text:

Yang GJ, Liu L, Zhu HR, Griffiths SM, Tanner M, Bergquist R, Utzinger J, Zhou XN.
China's sustained drive to eliminate neglected tropical diseases. Lancet Infect Dis. 2014 Sep;14(9):881-92. Read abstract:

Zhang DF, Wang D, Li YY, Yao YG. Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese. Genes Immun. 2014 Oct;15(7):506-10. Read abstract:


New Key Topic Pages


Keytopics are collections of information, publications and links on a particular leprosy related subject. Infolep helps you locate the resources you need by compiling Keytopic lists that highlight information resources on leprosy-related topics, selected and reviewed by field experts.


ILEP Model Patient Record (Leprosy)

SARI Project - Stigma Assessment and Reduction of Impact

Journals  & Newsletters


Clinics in Dermatology, Jan, Feb 2015, Special issue on leprosy:

Disability, CBR & Inclusive Development:

Leprosy Review:

WHO Goodwill Ambassador's Newsletter for the elimination of leprosy:

Jiske Erlings

Medewerker InfoLep / Information Officer

Infolep Leprosy Information Services

Postbus / P.O. Box 95005

1090 HA Amsterdam

The Netherlands


+31 20 5950530







LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link:

Contact: Dr Pieter Schreuder <<

This email has been checked for viruses by Avast antivirus software.